Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Booster HAV Vaccination in HIV-infected Non-responders
NCT03855176Phase 4Completed
- Sponsor
- National Taiwan University Hospital
- Start
- Sep 2017
- Primary completion
- Dec 2022
- Modality
- Whole Inactivated Vaccines
- Countries
- 1
01
Overview
Phase 4, randomised trial of Hepatitis A virus vaccine in hepatitis A (HAV) (2 arms), sponsored by National Taiwan University Hospital. Primary endpoint: Serological responses at week 48. Started Sep 2017; status: completed.
02
Drugs
Hepatitis A virus vaccine
03
Conditions
hepatitis A (HAV)
Beyond the preview
Go deeper on NCT03855176.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03855176.